vs

Side-by-side financial comparison of MSC INDUSTRIAL DIRECT CO INC (MSM) and BeOne Medicines Ltd. (ONC). Click either name above to swap in a different company.

BeOne Medicines Ltd. is the larger business by last-quarter revenue ($1.5B vs $965.7M, roughly 1.6× MSC INDUSTRIAL DIRECT CO INC). MSC INDUSTRIAL DIRECT CO INC runs the higher net margin — 5.4% vs 4.4%, a 0.9% gap on every dollar of revenue. On growth, BeOne Medicines Ltd. posted the faster year-over-year revenue change (32.8% vs 4.0%). BeOne Medicines Ltd. produced more free cash flow last quarter ($379.8M vs $7.4M). Over the past eight quarters, BeOne Medicines Ltd.'s revenue compounded faster (41.2% CAGR vs -3.4%).

MSC Industrial Direct Co., Inc (MSC), through its subsidiaries, primarily MSC Industrial Supply Co., is one of the largest industrial equipment distributors in the United States, distributing more than 1.5 million metalworking and other industrial products.

BeOne Medicines, formerly known as BeiGene, Ltd. is a multinational oncology company. It specializes in the development of drugs for cancer treatment.

MSM vs ONC — Head-to-Head

Bigger by revenue
ONC
ONC
1.6× larger
ONC
$1.5B
$965.7M
MSM
Growing faster (revenue YoY)
ONC
ONC
+28.8% gap
ONC
32.8%
4.0%
MSM
Higher net margin
MSM
MSM
0.9% more per $
MSM
5.4%
4.4%
ONC
More free cash flow
ONC
ONC
$372.4M more FCF
ONC
$379.8M
$7.4M
MSM
Faster 2-yr revenue CAGR
ONC
ONC
Annualised
ONC
41.2%
-3.4%
MSM

Income Statement — Q1 FY2026 vs Q4 FY2025

Metric
MSM
MSM
ONC
ONC
Revenue
$965.7M
$1.5B
Net Profit
$51.8M
$66.5M
Gross Margin
40.7%
90.5%
Operating Margin
7.9%
12.4%
Net Margin
5.4%
4.4%
Revenue YoY
4.0%
32.8%
Net Profit YoY
11.1%
143.8%
EPS (diluted)
$0.93
$0.05

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
MSM
MSM
ONC
ONC
Q4 25
$965.7M
$1.5B
Q3 25
$978.2M
$1.4B
Q2 25
$971.1M
$1.3B
Q1 25
$1.1B
Q4 24
$928.5M
$1.1B
Q3 24
$1.0B
Q2 24
$979.4M
$929.2M
Q1 24
$935.3M
$751.7M
Net Profit
MSM
MSM
ONC
ONC
Q4 25
$51.8M
$66.5M
Q3 25
$56.5M
$124.8M
Q2 25
$56.8M
$94.3M
Q1 25
$1.3M
Q4 24
$46.6M
$-151.9M
Q3 24
$-121.3M
Q2 24
$71.7M
$-120.4M
Q1 24
$61.8M
$-251.2M
Gross Margin
MSM
MSM
ONC
ONC
Q4 25
40.7%
90.5%
Q3 25
40.4%
86.1%
Q2 25
41.0%
87.5%
Q1 25
85.2%
Q4 24
40.7%
85.8%
Q3 24
83.0%
Q2 24
40.9%
85.1%
Q1 24
41.5%
83.4%
Operating Margin
MSM
MSM
ONC
ONC
Q4 25
7.9%
12.4%
Q3 25
8.6%
11.5%
Q2 25
8.5%
6.7%
Q1 25
1.0%
Q4 24
7.8%
-7.0%
Q3 24
-12.0%
Q2 24
10.9%
-11.5%
Q1 24
9.7%
-34.8%
Net Margin
MSM
MSM
ONC
ONC
Q4 25
5.4%
4.4%
Q3 25
5.8%
8.8%
Q2 25
5.9%
7.2%
Q1 25
0.1%
Q4 24
5.0%
-13.5%
Q3 24
-12.1%
Q2 24
7.3%
-13.0%
Q1 24
6.6%
-33.4%
EPS (diluted)
MSM
MSM
ONC
ONC
Q4 25
$0.93
$0.05
Q3 25
$1.02
$0.08
Q2 25
$1.02
$0.06
Q1 25
$0.00
Q4 24
$0.83
$-0.10
Q3 24
$-0.09
Q2 24
$1.27
$-0.09
Q1 24
$1.10
$-0.19

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
MSM
MSM
ONC
ONC
Cash + ST InvestmentsLiquidity on hand
$40.3M
$4.5B
Total DebtLower is stronger
$214.1M
$836.4M
Stockholders' EquityBook value
$1.4B
$4.4B
Total Assets
$2.5B
$8.2B
Debt / EquityLower = less leverage
0.16×
0.19×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
MSM
MSM
ONC
ONC
Q4 25
$40.3M
$4.5B
Q3 25
$56.2M
$4.0B
Q2 25
$71.7M
$2.8B
Q1 25
$2.5B
Q4 24
$57.3M
$2.6B
Q3 24
$2.7B
Q2 24
$25.9M
$2.6B
Q1 24
$22.2M
$2.8B
Total Debt
MSM
MSM
ONC
ONC
Q4 25
$214.1M
$836.4M
Q3 25
$168.8M
Q2 25
$285.0M
Q1 25
Q4 24
$289.9M
Q3 24
Q2 24
$299.8M
Q1 24
$294.5M
Stockholders' Equity
MSM
MSM
ONC
ONC
Q4 25
$1.4B
$4.4B
Q3 25
$1.4B
$4.1B
Q2 25
$1.4B
$3.8B
Q1 25
$3.5B
Q4 24
$1.4B
$3.3B
Q3 24
$3.4B
Q2 24
$1.4B
$3.4B
Q1 24
$1.4B
$3.4B
Total Assets
MSM
MSM
ONC
ONC
Q4 25
$2.5B
$8.2B
Q3 25
$2.5B
$7.6B
Q2 25
$2.5B
$6.3B
Q1 25
$5.8B
Q4 24
$2.5B
$5.9B
Q3 24
$5.8B
Q2 24
$2.5B
$5.7B
Q1 24
$2.5B
$5.7B
Debt / Equity
MSM
MSM
ONC
ONC
Q4 25
0.16×
0.19×
Q3 25
0.12×
Q2 25
0.21×
Q1 25
Q4 24
0.21×
Q3 24
Q2 24
0.21×
Q1 24
0.21×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
MSM
MSM
ONC
ONC
Operating Cash FlowLast quarter
$29.4M
$417.3M
Free Cash FlowOCF − Capex
$7.4M
$379.8M
FCF MarginFCF / Revenue
0.8%
25.4%
Capex IntensityCapex / Revenue
2.3%
2.5%
Cash ConversionOCF / Net Profit
0.57×
6.28×
TTM Free Cash FlowTrailing 4 quarters
$941.7M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
MSM
MSM
ONC
ONC
Q4 25
$29.4M
$417.3M
Q3 25
$402.6M
Q2 25
$151.6M
$263.6M
Q1 25
$44.1M
Q4 24
$101.9M
$75.2M
Q3 24
$188.4M
Q2 24
$143.5M
$-95.6M
Q1 24
$78.7M
$-308.6M
Free Cash Flow
MSM
MSM
ONC
ONC
Q4 25
$7.4M
$379.8M
Q3 25
$354.5M
Q2 25
$100.7M
$219.8M
Q1 25
$-12.3M
Q4 24
$81.7M
$-17.3M
Q3 24
$54.7M
Q2 24
$114.0M
$-205.5M
Q1 24
$53.4M
$-465.1M
FCF Margin
MSM
MSM
ONC
ONC
Q4 25
0.8%
25.4%
Q3 25
25.1%
Q2 25
10.4%
16.7%
Q1 25
-1.1%
Q4 24
8.8%
-1.5%
Q3 24
5.5%
Q2 24
11.6%
-22.1%
Q1 24
5.7%
-61.9%
Capex Intensity
MSM
MSM
ONC
ONC
Q4 25
2.3%
2.5%
Q3 25
3.4%
Q2 25
5.2%
3.3%
Q1 25
5.0%
Q4 24
2.2%
8.2%
Q3 24
13.3%
Q2 24
3.0%
11.8%
Q1 24
2.7%
20.8%
Cash Conversion
MSM
MSM
ONC
ONC
Q4 25
0.57×
6.28×
Q3 25
3.22×
Q2 25
2.67×
2.79×
Q1 25
34.71×
Q4 24
2.18×
Q3 24
Q2 24
2.00×
Q1 24
1.27×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons